MultiQure S.A. (FRA:PQB)

Market Cap	76.12M +1,174.8%
Revenue (ttm)	n/a
Net Income	-35.83M
EPS	-3.67
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Open	0.2495
Previous Close	0.2570
Day's Range	0.2495 - 0.2495
52-Week Range	0.2260 - 1.3860
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About MultiQure

MultiQure S.A., a biopharmaceutical company, researches and develops biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFβ1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the αVβ8 integrin. The company was formerly known as Pure Biologics S.A. and changed its name to MultiQure S.A. in August 2026. The company was founded in 2013 and is based in Wroclaw, Poland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PQB

Financial Performance

Financial numbers in PLN

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error